Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
10/2000
10/26/2000WO2000026197A9 Novel inhibitors of impdh enzyme
10/26/2000WO2000025808A8 Inhibition of differentiation of cytotoxic t-cells by p-selectin ligand (psgl) antagonists
10/26/2000WO2000019976A9 Biodegradable terephthalate polyester-poly(phosphonate) and polyester-poly(phosphite) compositions, articles, and methods of using them
10/26/2000WO2000018230A9 Combination of bisphosphonate and tetracycline
10/26/2000WO2000017191A3 N-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them
10/26/2000WO2000017190A3 Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same
10/26/2000DE19918211A1 New 2-carbocyclyl-benzimidazole-carboxamide derivatives, are PARP inhibitors useful e.g. for treating neurodegenerative disease, epilepsy, ischemia, tumors, inflammation or diabetes
10/26/2000DE19917696A1 Biological restoration agent, e.g. for filling bone defects, comprising a carrier coated with or including an active complex of structural, recruiting, adhesion and growth or maturation components
10/26/2000DE19860802A1 Herstellung eines Mittels gegen Hepatitis B-, HI-, Paramyxo und Orthomyxo-Viren Production of an agent against hepatitis B, HI, and Paramyxo orthomyxovirus viruses
10/26/2000DE10017883A1 Neues Behandlungsverfahren New treatment methods
10/26/2000CA2371942A1 Pseudomycin antifungal compositions and methods for their use
10/26/2000CA2371399A1 Skin care compositions containing combination of skin care actives
10/26/2000CA2371389A1 Beta-lactamase inhibiting 7-alkyldiene cephalosporanic acid derivatives
10/26/2000CA2371363A1 Antifungal agents isolated from pseudomonas syringae
10/26/2000CA2370743A1 Ketolide antibacterials
10/26/2000CA2370708A1 Vaccine comprising rsv antigen and cpg oligonucleotide
10/26/2000CA2370646A1 Nucleic acid immunization
10/26/2000CA2370628A1 Methods and compositions for inhibiting the function of polynucleotide sequences
10/26/2000CA2370602A1 Adipocyte complement related protein homolog zacrp2
10/26/2000CA2370417A1 Substituted azoles
10/26/2000CA2370296A1 Improvement of t cell mediated immunity
10/26/2000CA2370273A1 Novel 8a- and 9a-15-membered lactams
10/26/2000CA2370239A1 Pseudomycin production by pseudomonas syringae
10/26/2000CA2370231A1 Haloalkoxy imidazonaphthyridines
10/26/2000CA2370129A1 Methods and compositions for modulating an immune response
10/26/2000CA2370127A1 Novel method of treatment
10/26/2000CA2369886A1 Macrolide antiinfective agents
10/26/2000CA2369816A1 Macrolide antiinfective agents
10/26/2000CA2369762A1 A method for improving the half-life of soluble viral-specific ligands on mucosal membranes
10/26/2000CA2369633A1 A multi-plasmid method for preparing large libraries of polyketides and non-ribosomal peptides
10/26/2000CA2369136A1 Pseudomycin natural products
10/26/2000CA2368029A1 Pharmaceutical composition comprising pim-activated nkt cells, and therapeutic use thereof
10/26/2000CA2367359A1 Dibenzoazulene derivatives for the treatment of thrombosis, osteoporosis, arteriosclerosis
10/26/2000CA2365579A1 Combination vaccine against streptococcus pneumoniae and respiratory syncytial virus (rsv)
10/26/2000CA2365523A1 Identification of sortase gene
10/26/2000CA2364209A1 49 human secreted proteins
10/26/2000CA2363945A1 Novel ribose-substituted aromatic amides, method for the production and use thereof as medicaments
10/26/2000CA2330022A1 Low adenosine anti-sense oligonucleotide, compositions, kit and method for treatment of airway disorders associated with bronchoconstriction, lung inflammation, allergy(ies) and surfactant depletion
10/25/2000EP1046399A1 HCV combination therapy, containing ribavirin in association with antioxidants
10/25/2000EP1045901A1 Ribozymal nucleic acids cleaving ccr5 or cxcr4
10/25/2000EP1045859A1 NOVEL SURFACE PROTEIN OF $i(NEISSERIA MENINGITIDIS)
10/25/2000EP1045858A1 Anti-cryptococcal peptides
10/25/2000EP1045856A1 Novel aromatic amides, preparation method and application as medicines
10/25/2000EP1045850A1 Purine compounds having pde iv inhibitory activity and methods of synthesis
10/25/2000EP1045849A1 Purine derivatives having phosphodiesterase iv inhibition activity
10/25/2000EP1045845A1 N-oxides of heterocyclic compounds with tnf and pde-iv inhibiting activity
10/25/2000EP1045832A2 Novel urethanes, thio and dithio analogues, the salts thereof, medicaments containing said compounds, use and method for the production thereof
10/25/2000EP0804088B1 Stabilized composition comprising colistin sulfate
10/25/2000EP0736039B1 Compounds with growth hormone releasing properties
10/25/2000CN1271386A Amino-terminally trancated RANTES as chemokine antagonists
10/25/2000CN1271385A Amino-terminally truncated MCP-2 as chemokine antagnosits
10/25/2000CN1271363A 3'-N-modified 6-0-substituted erythromycin ketolide derivatives having antibacterial activity
10/25/2000CN1271361A Tetrazole-containing rapamycin analogs with shortened half-lives
10/25/2000CN1271358A Oxazolidinone derivatives and pharmaceutical compositions
10/25/2000CN1271356A Tetrahydrofuran phosphate- and hydroxy esters, as prodrugs for corresponding antifungal agent
10/25/2000CN1271292A Combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection
10/25/2000CN1271281A Medicamenet formulation with a controlled release of an active agent
10/25/2000CN1270838A Adjuvant used in vaccine
10/25/2000CN1270826A Chinese medicine preparation for pulmonary tuberculosis and its preparation
10/25/2000CN1270818A Antiphlogistic and analgesic medicine and its application
10/25/2000CN1057774C 乙型肝炎疫苗 Hepatitis B Vaccine
10/25/2000CN1057693C Hepatitis B virus converting negative tablet
10/25/2000CN1057679C Traditional Chinese medicines antiphthitic preparation
10/24/2000US6136863 Antifungal agents
10/24/2000US6136839 Using a sulfone or sulfoamide benzene compound
10/24/2000US6136815 Antiviral 2,4-pyrimidinedione derivatives and process for the preparation thereof
10/24/2000US6136813 Viricides for hepatitis b
10/24/2000US6136797 Phospholipid derivatives of phosphono-carboxylic acids, the production of said derivatives and the use of said derivatives as antiviral medicaments
10/24/2000US6136790 Carbohydrate mimetics having antiadhesive properties
10/24/2000US6136602 Nucleotide sequences which can hybridize to preferential target nucleic acids; for the suppression of the expression of genes associated with antibiotic resistance and the prevention of bacterial infections
10/24/2000US6136556 TCTS response regulator
10/24/2000US6136527 Polypeptides derived from proteins of the hepatitis C virus, test kits containing these polypeptides and vaccines against infections of hepatitis C viruses
10/24/2000US6136344 Oral pharmaceutical dosage form
10/24/2000US6136338 Given dosage of difloxacin or salt thereof in inert carrier
10/24/2000US6136335 Phenethyl-5-bromopyridylthiourea (PBT) and dihydroalkoxybenzyloxopyrimidine (DABO) derivatives exhibiting spermicidal activity
10/24/2000US6136332 Dermatological/pharmaceutical compositions comprising volatile oils/phenylated silicone oils
10/24/2000US6136325 Live vaccine constituting minor risk for humans
10/24/2000US6136324 Deactivating tuberculosis gene
10/24/2000US6136321 Incubation in a polysorbate
10/24/2000US6136320 Orally acceptable immunogenic composition
10/24/2000US6136319 Method of treating viral diseases in animals
10/24/2000US6136318 Genetic engineering
10/24/2000US6136315 Compositions and methods using complexes of heat shock protein 70 and antigenic molecules for the treatment and prevention of neoplastic diseases
10/24/2000US6136312 Method for producing an IgM preparation for intravenous application
10/24/2000US6136307 Reovirus for the treatment of cellular proliferative disorders
10/24/2000CA2220873C Method for reproducing in vitro the rna-dependent rna polymerase and terminal nucleotidyl transferase activities encoded by hepatitis c virus (hcv)
10/24/2000CA2139664C Covalent polar lipid-peptide conjugates for biological targeting
10/24/2000CA2124814C 2'-deoxy-isoquanosines, isosteric analogues and isoquanosine derivatives as well as their use
10/24/2000CA2024497C Chemical derivatives of antibiotics ll-f19020 alpha and beta
10/19/2000WO2000062067A1 Novel transduction molecules and methods for using same
10/19/2000WO2000061804A1 Tissue-specific and pathogen-specific toxic agents and ribozymes
10/19/2000WO2000061793A2 Novel method for identifying antibacterial compounds
10/19/2000WO2000061792A1 Novel essential bacterial genes and their proteins
10/19/2000WO2000061783A2 Process for preparing inhibitors of nucleoside metabolism
10/19/2000WO2000061779A1 49 human secreted proteins
10/19/2000WO2000061774A2 Bone morphogenic proteins
10/19/2000WO2000061772A2 Compositions and methods for generating an immune response utilizing alphavirus-based vector systems
10/19/2000WO2000061762A1 RECOMBINANT TOXIN A/TOXIN B VACCINE AGAINST $i(CLOSTRIDIUM DIFFICILE)
10/19/2000WO2000061761A2 Recombinant clostridium toxin a protein carrier for polysaccharide conjugate vaccines
10/19/2000WO2000061757A1 Tumor necrosis factor homologs and nucleic acids encoding the same
1 ... 1432 1433 1434 1435 1436 1437 1438 1439 1440 1441 1442 1443 1444 1445 1446 1447 1448 1449 1450 1451 1452 ... 1798